Page 3 - Multiple Sclerosis Relapse News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A form of apheresis called immunoadsorption alleviates the symptoms better than the usual therapy with high-dose methylprednisolone, researchers found in a German study.

Although serum glial fibrillary acid protein (GFAP) could be a useful complement to the multiple sclerosis biomarker neurofilament light chain (NfL), it is not ready for the clinic, experts say.

Two studies report few complications from continuing ocrelizumab and natalizumab into pregnancy, with high live birth rates, a decline in elective abortions, and few major congenital abnormalities in newborns.

Lower cardiorespiratory fitness predicts increased variability in stride time in people with MS and may serve as a biomarker of function decline.

Autologous hematopoietic stem cell transplantation is linked to significantly lower relapse rates than fingolimod in patients with relapsing-remitting multiple sclerosis. But adverse events are common.